BlueLinx (BXC) had the highest return between January 1, 2018 and March 30, 2018 by a small-cap US stock, returning 233.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
BlueLinx (BXC) | 1/1/2018 - 3/30/2018 | 233.57% |
Acm Research (ACMR) | 1/1/2018 - 3/30/2018 | 134.29% |
Geron (GERN) | 1/1/2018 - 3/30/2018 | 130.98% |
POET Technologies (POET) | 1/1/2018 - 3/30/2018 | 123.53% |
Tandem Diabetes Care (TNDM) | 1/1/2018 - 3/30/2018 | 111.06% |
Iovance Biotherapeutics (IOVA) | 1/1/2018 - 3/30/2018 | 108.64% |
Zevra Therapeutics (ZVRA) | 1/1/2018 - 3/30/2018 | 95.06% |
Gyre Therapeutics (GYRE) | 1/1/2018 - 3/30/2018 | 89.15% |
NuCana (NCNA) | 1/1/2018 - 3/30/2018 | 82.8% |
Spyre Therapeutics (SYRE) | 1/1/2018 - 3/30/2018 | 82.35% |
Vericel Corp Ord (VCEL) | 1/1/2018 - 3/30/2018 | 79.28% |
Nektar Therapeutics (NKTR) | 1/1/2018 - 3/30/2018 | 78.38% |
Eastman Kodak (KODK) | 1/1/2018 - 3/30/2018 | 75.41% |
Rocket Pharmaceuticals (RCKT) | 1/1/2018 - 3/30/2018 | 73.61% |
Novavax (NVAX) | 1/1/2018 - 3/30/2018 | 70.73% |
American Public Education (APEI) | 1/1/2018 - 3/30/2018 | 69.96% |
Syndax Pharmaceuticals (SNDX) | 1/1/2018 - 3/30/2018 | 62.81% |
Larimar Therapeutics (LRMR) | 1/1/2018 - 3/30/2018 | 59.87% |
Zymeworks Inc Common Stock (ZYME) | 1/1/2018 - 3/30/2018 | 56.31% |
Perpetua Resources (PPTA) | 1/1/2018 - 3/30/2018 | 53.05% |
Know Labs (KNW) | 1/1/2018 - 3/30/2018 | 52.38% |
QuinStreet (QNST) | 1/1/2018 - 3/30/2018 | 52.02% |
Ameresco (AMRC) | 1/1/2018 - 3/30/2018 | 51.16% |
Hello (MOMO) | 1/1/2018 - 3/30/2018 | 50.48% |
InnovAge (INNV) | 1/1/2018 - 3/30/2018 | 47.35% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
